Official recall notice

FDA DrugClass IINotable

FDA Recall: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45

Recall date
2026-09-02
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Subpotent Drug

Product description

Subpotent Drug

Affected products

a) Lot #: D2402642, Exp. Date 11/30/2026 b) Lot #: D2401832, Exp. Date 08/31/2026; D2402525, D2402527, D2402526, D2402644, D2402643, Exp. Date 11/30/2026.

Verify with the official notice →
Share:

Related Recalls

2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.